From: Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study
Demographic data | Subjects with ovarian cancer | Subjects without ovarian cancer | P | ||
---|---|---|---|---|---|
n = 8,810 | n = 8,810 | ||||
 | n | % | n | % |  |
Age (interquartile range) | 49 (41 to 58) | Â | 49 (41 to 58) | Â | 1.000 |
  ≥50 years | 4,357 | 49.5 | 4,357 | 49.5 | 1.000 |
  <50 years | 4,453 | 50.5 | 4,453 | 50.5 |  |
Comorbidities | Â | Â | Â | Â | Â |
  Diabetes mellitus | 1,446 | 16.4 | 1,447 | 16.4 | 0.984 |
  Hypertension | 2,425 | 27.5 | 2,426 | 27.5 | 0.987 |
  Chronic kidney disease | 709 | 8.0 | 708 | 8.0 | 0.978 |
  Dyslipidemia | 1,987 | 22.6 | 1,986 | 22.5 | 0.986 |
  Coronary artery disease | 52 | 0.6 | 50 | 0.6 | 0.843 |
  Atrial fibrillation | 47 | 0.5 | 45 | 0.5 | 0.834 |
  Peripheral arterial occlusive disease | 19 | 0.2 | 17 | 0.2 | 0.739 |
Treatment | Â | Â | Â | Â | Â |
  Surgery | 6,160 | 69.9 |  |  |  |
  Chemotherapy | 6,590 | 74.8 |  |  |  |
  Cisplatin-based | 3,093 | 35.1 |  |  |  |
  Carboplatin-based | 5,041 | 57.2 |  |  |  |
  Non-platinum-based | 402 | 4.6 |  |  |  |